Author

Wie Fang

Institution: ORIC Pharmaceuticals, Inc. (United States)

Observed institution: ORIC Pharmaceuticals, Inc. (United States)

OpenAlex ID: A5040468424

Abstract 4998: Selective PLK4 inhibition demonstrates synthetic lethality in TRIM37 amplified neuroblastoma and breast cancer models while less selective inhibitors do not

2023 · Siobhan K. McRee, Chelsea Chen, et al. · Cancer Research

Works count: 1

Citation count:

H-index:

I10-index: